NL194067B - Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. - Google Patents

Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.

Info

Publication number
NL194067B
NL194067B NL8701743A NL8701743A NL194067B NL 194067 B NL194067 B NL 194067B NL 8701743 A NL8701743 A NL 8701743A NL 8701743 A NL8701743 A NL 8701743A NL 194067 B NL194067 B NL 194067B
Authority
NL
Netherlands
Prior art keywords
acetylcysteine
aspartame
water soluble
formulation containing
effervescent formulation
Prior art date
Application number
NL8701743A
Other languages
English (en)
Other versions
NL194067C (nl
NL8701743A (nl
Original Assignee
Inpharzam Internat S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam Internat S A filed Critical Inpharzam Internat S A
Publication of NL8701743A publication Critical patent/NL8701743A/nl
Publication of NL194067B publication Critical patent/NL194067B/nl
Application granted granted Critical
Publication of NL194067C publication Critical patent/NL194067C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8701743A 1986-07-24 1987-07-23 Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. NL194067C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2975/86A CH667590A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
CH297586 1986-07-24

Publications (3)

Publication Number Publication Date
NL8701743A NL8701743A (nl) 1988-02-16
NL194067B true NL194067B (nl) 2001-02-01
NL194067C NL194067C (nl) 2001-06-05

Family

ID=4245841

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701743A NL194067C (nl) 1986-07-24 1987-07-23 Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.

Country Status (8)

Country Link
BE (1) BE1000355A3 (nl)
CH (1) CH667590A5 (nl)
DE (1) DE3723735A1 (nl)
FR (1) FR2601876B1 (nl)
GB (1) GB2192790B (nl)
IT (1) IT1222104B (nl)
NL (1) NL194067C (nl)
SE (1) SE500494C2 (nl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
DE69209335T2 (de) * 1991-01-26 1996-08-29 Senju Pharma Co Mittel zur Zersetzung von Gallensteinen
DE4103360A1 (de) * 1991-02-05 1992-08-06 Koehler Peter Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
DE19509856C2 (de) * 1995-03-17 1997-09-11 Schwabe Willmar Gmbh & Co Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen
EP1115842A4 (en) 1998-09-25 2002-08-21 Glycox Corp Ltd DETERMINATION OF FRUCTOSAMINE OXIDASE: METHODS AND SUBSTANCES
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
WO2003077901A1 (en) 2002-03-08 2003-09-25 Protemix Corporation Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
JP2006503014A (ja) 2002-08-20 2006-01-26 プロテミックス コーポレイション リミティド 剤形及び関連する治療法
ES2449066T3 (es) 2004-07-19 2014-03-18 Philera New Zealand Limited Síntesis de trietilentetraminas
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102233139B (zh) * 2010-04-21 2012-09-05 重庆健能医药开发有限公司 一种乙酰半胱氨酸泡腾片及其制备方法和应用
EP2571499A1 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Pharmaceutical composition comprising n- acetylcysteine and a xanthine
CN101947211A (zh) * 2010-08-28 2011-01-19 浙江金华康恩贝生物制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法
TR201104738A2 (tr) * 2011-05-16 2012-12-21 Bi̇lgi̇ç Mahmut N-Asetilsistein içeren farmasötik kombinasyon.
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine
EP2905020A1 (en) 2014-02-05 2015-08-12 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations comprising ibuprofen and N-acetylcystein
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
ZA723683B (en) * 1971-07-12 1973-06-27 Hoffmann La Roche Improved effervescent preparations
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Also Published As

Publication number Publication date
SE8702940D0 (sv) 1987-07-23
FR2601876A1 (fr) 1988-01-29
DE3723735A1 (de) 1988-02-04
SE8702940L (sv) 1988-01-25
NL194067C (nl) 2001-06-05
BE1000355A3 (fr) 1988-11-08
CH667590A5 (it) 1988-10-31
IT8721411A0 (it) 1987-07-23
GB2192790A (en) 1988-01-27
IT1222104B (it) 1990-08-31
FR2601876B1 (fr) 1989-10-13
DE3723735C2 (nl) 1992-05-21
GB8717582D0 (en) 1987-09-03
GB2192790B (en) 1990-01-31
SE500494C2 (sv) 1994-07-04
NL8701743A (nl) 1988-02-16

Similar Documents

Publication Publication Date Title
NL194067B (nl) Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.
NL194154B (nl) Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat.
ATE200977T1 (de) Depigmentierendes pharmazeutisches oder kosmetisches mittel mit kaffeinsäure
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
IT1245849B (it) Procedimento per rivelare la concentrazione di un ingrediente attivo in un sistema acquoso
DK127787A (da) Interleukin-1alfa-derivater og medikamenter indeholdende saadanne derivater
DK346486A (da) Aminosalicylsyrederivater og farmaceutiske midler
MC2112A1 (fr) Comprime effervescent
BR8700808A (pt) Polimero contendo amida,substituida,pendente,soluvel em agua
DE3680796D1 (de) Chinolincarbonsaeuretabletten und formulierungen.
DK127887A (da) Interleukin-1beta-derivater og medikamenter indeholdende saadanne derivater
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DE3682960D1 (de) Pharmazeutische praeparate.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
MX5577A (es) Formulacion farmaceutica
DK131987A (da) Indretning til at forstyrre og narre stedbestemmelsesanlaeg for lyd i vandet
IT8520591A0 (it) Formulazione farmaceutica.
DK392187A (da) Isoquinolinderivater og farmaceutiske praeparater indeholdende dem
DK161303C (da) Hostestillende oralt praeparat indeholdende noscapinembonat og en fremgangsmaade til fremstillling deraf samt noscapinsalt til anvendelse i det hosestillende orale praeparat
IT1237515B (it) Procedimento per la preparazione di primicina idrosolubile e suoi componenti e composizioni farmaceutiche che li contengono.
DK36387D0 (da) Desinficerende og steriliserende praeparat
DK616087D0 (da) Isoquinolinderivater og farmaceutiske praeparater indeholdende dem
PT85350A (de) Xylometazolinhaltige pharmazeutische praeparate
DK553285D0 (da) Fenoxypropanolaminsalte og farmaceutiske praeparater deraf
DK220786D0 (da) Ascorbinsyrederivater og fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: INPHARZAM S.A.

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070723